MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $0 | – | 13 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 13 | -73.5% | 0.00% | – |
| Q4 2019 | $1,000 | -50.0% | 49 | -22.2% | 0.00% | – |
| Q3 2019 | $2,000 | -80.0% | 63 | -77.2% | 0.00% | -100.0% |
| Q2 2019 | $10,000 | +400.0% | 276 | +338.1% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 63 | +8.6% | 0.00% | – |
| Q4 2018 | $2,000 | -84.6% | 58 | -79.6% | 0.00% | -100.0% |
| Q3 2018 | $13,000 | +30.0% | 284 | +2.9% | 0.00% | +50.0% |
| Q2 2018 | $10,000 | – | 276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |